Neurofibromatosis I: Recommendations for management;Neurofibromatose I: Recommandations pour la prise en charge

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 4, 2001, Pages 567-575

  Pinson, S ^a   Creange A ^b   Barbarot, S ^c   Stalder, J F ^c   Chaix, Y ^d   Rodriguez, D ^e   Sanson, M ^f   Bernheim, A ^g   D'Incan, M ^h   Doz, F ⁱ   Stoll, Cl ^j   Combemale, P ^k   Kalifa, C ^g   Zeller, J ^b   Teillac Hamel, D ^l   Lyonnet, S ^l   Zerah, M ^l   Lacour, J Ph ^m   Guillot, B ⁿ   Wolkenstein, P ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔTEL DIEU   (France)

^d HÔPITAL DES ENFANTS   (France)

^e HÔPITAL SAINT VINCENT DE PAUL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h HÔTEL DIEU   (France)

ⁱ INSTITUT CURIE   (France)

^j HÔPITAL DE HAUTEPIERRE   (France)

^k HIA Desgenettes   (France)

^l HÔPITAL NECKER ENFANTS MALADES   (France)

^m CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁿ Dermatologie   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN; PROTEIN P21;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CAFE AU LAIT SPOT; CELL PROLIFERATION; CHROMOSOME 17; DYSPLASIA; EPILEPSY; HUMAN; HYDROCEPHALUS; LEUKEMIA; NEUROFIBROMA; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PENETRANCE; PHEOCHROMOCYTOMA; PSEUDARTHROSIS; SCOLIOSIS; ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; CHILD; DIFFERENTIAL DIAGNOSIS; FRANCE; GENETICS; INCIDENCE; ONSET AGE; PRACTICE GUIDELINE; PRESCHOOL CHILD; REGISTER; REVIEW;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FRANCE; HUMANS; INCIDENCE; NEUROFIBROMATOSIS 1; PRACTICE GUIDELINES; REGISTRIES;

EID: 0034743963     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The neurofibromatoses : a pathogenetic and clinical overview. Huson SM, Hughes RAC eds. Chapmann and Hall, London, 1994.
2. Neurofibromatosis : Phenotype, natural history, and pathogenesis. Friedman JM, Gutmann DH, MacCollin M, Riccardi VM. Johns Hopkins University Press, Baltimore, 1999.
3. Neurofibromatoses : a handbook for patients, families, and health-care professionals. Rubenstein AE, Korf BR. Thieme Medical Publishers, Inc, New York, 1990.
4. Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617-27.
5. Ledbetter DH, Rich DC, O'Connell P, Leppert M, Carey JC. Precise localization of NF1 to 17q11.2 by balanced translation. Am J Hum Genet 1989;44:20-4.
6. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996;33:2-17.
7. Bahuau M, Vidaud M, Vidaud D. Revue : Neurofibromatose. Génétique et physiopathologic moléculaire de la NF1. M/T 1997;8:623-8.
8. Gutmann DH, Collins FS. Neurofibromatosis type 1. Beyond positional cloning. Arch Neurol 1993;50:1185-93.
9. Huson SM, Compston DAS, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in South East Wales. II : Guidelines for genetic counselling. J Med Genet 1989;26:712-21.
10. NIH Consensus Developement Conference Statement. Neurofibromatosis. Arch Neurol 1988;45:575-8.
11. Zeller J, Hovnanian A. La maladie de von Recklinghausen. Ann Dermatol Venereol 1992; 119:405-10.
12. Kopf AW, Levine LJ, Rigel DS, Friedman RJ, Levenstein M. Prevalence of congenital-nevus-like nevi, nevi spili, and cafe au lait spots. Arch Dermatol 1985;121:766-9.
13. Obringer AC, Meadows AT, Zackai EH. The diagnosis of neurofibromatosis 1 in the child under the age of 6 years. Am J Dis Child 1989;143:717-9.
14. Listernick R, Darling C, Greenwald M, Strauss L, Charrow J. Optic pathway tumors in children : the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 1995;127:718-22.
15. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1 : consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997;41:143-9.
16. Friedman JM, Birch PH. Type 1 neurofibromatosis - a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997;70:138-43.
17. Samuelsson B, Axelsson R. Neurofibromatosis : A clinical and genetic study of 96 cases in Gothenburg, Sweden. Acta Derm Venereol 1981 ; S95:67-71.
18. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986;314:1010-5.
19. Zoller M, Rembeck B, Akesson HO, Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm Venereol 1995; 75:136-40.
20. Créange A, Zeller J, Brugières P, Rostaing-Rogattieri S, Degos JD, Revuz J, Wolkenstein P. Neurological complications in adult patients with neurofibromatosis type 1 (NF1). Brain 1999;122:473-81.
21. Ferner RE, Hughes RA, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neur Sci 1996;138:125-33.
22. North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Denckla MB. Cognitive function and academic performance in neurofibromatosis. 1 : consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 1997;48:1121-7.
23. Lund AM, Skovby F. Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr 1991;150:835-8.
24. Grill J, Couanet D, Cappelli C, Habrand JL, Rodriguez D, Sainte-Rose C, Kalifa C. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 1999;45:393-6.
25. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuda J-I. Neurofibromatosis type 1 and childhood cancer. Cancer 1993;72: 2746-54.
26. Eichenfield LF, Levy ML, Paller AS, Riccardi VM, Farmer ER, Chuang, TY, et al. Guidelines of care for neurofibromatosis type 1. J Am Acad Dermatol 1997;37:625-30.
27. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-7.
28. Wolkenstein P, Frèche B, Zeller J, Revuz J. Usefulness of screening investigations in neurofibromatosis type 1 : a study of 152 patients. Arch Dermatol 1996;132:1333-6.
29. Huson SM. What level of care for the neurofibromatoses ? Lancet 1999;353:1114-6.